In recognition of this new challenge the WHO has set up a global task force on XDR-TB. Key
areas for action include the expansion of laboratory facilities for mycobacterial culture and …

Surveillance studies and outbreak investigations indicate that an extensively drug‐resistant
(XDR) form of tuberculosis (TB) is increasing in prevalence worldwide. In outbreak settings …

Throughout the world, eight million people develop active tuberculosis (TB) each year and
5,000 of them will die from this disease every day. Although treatable and curable, globally …

Extensively drug-resistant tuberculosis (XDR-TB) is defined as Mycobacterium tuberculosis
infection that is resistant to isoniazid, rifampin, any fluoroquinolone, and any injectable drug …

IN MARCH 2006, a report by the US Centers for Disease Control and Prevention (CDC) and
the World Health Organization (WHO) drew international attention to the emergence of …

Tuberculosis (TB) is an enormous global public health problem. Cases of extensively drug-
resistant TB (XDR-TB) are being reported in increasing numbers across the globe. A large …

Extensively drug-resistant (XDR)-TB, defined as TB with resistance to at least isoniazid,
rifampin, a fluoroquinolone and either amikacin, kanamycin or capreomycin, is a stark …

Tuberculosis (TB) is a devastating disease caused by Mycobacterium tuberculosis that killed
an estimated 4000-5000 person each day during 2005. Although infections with drug …

The phenomenon of multidrug-resistant tuberculosis (MDR-TB) emerged as a clinical entity
in the early 1990s after a couple of decades of widespread use of rifampin. A World Health …

Extensively drug-resistant tuberculosis : Current Opinion in Infectious Diseases Extensively
drug-resistant tuberculosis : Current Opinion in Infectious Diseases Log in or Register …